Fintel reports that on April 4, 2025, Redburn Atlantic downgraded their outlook for Qiagen N.V. (NYSE:QGEN) from Buy to ...
Redburn Atlantic began coverage on shares of Quest Diagnostics (NYSE:DGX – Free Report) in a report issued on Wednesday morning, MarketBeat reports. The firm issued a buy rating and a $195.00 price ...
Redburn Atlantic started coverage on shares of Laboratory Co. of America (NYSE:LH – Free Report) in a research note published on Wednesday, MarketBeat.com reports. The brokerage issued a buy rating ...